Antibody Maturation and Viral Diversification in HIV-Infected Women

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  James, Maria M ^a   Laeyendecker, Oliver ^a,b   Sun, Jin ^c   Hoover, Donald R ^d   Mullis, Caroline E ^a   Cousins, Matthew M ^a   Coates, Thomas ^e   Moore, Richard D ^a   Kelen, Gabor D ^a   Fowler, Mary Glenn ^a   Kumwenda, Johnstone J ^f   Mofenson, Lynne M ^g   Kumwenda, Newton I ^c   Taha, Taha E ^c   Eshleman, Susan H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MALAWI   (Malawi)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ALGORITHM; ANTIBODY RESPONSE; ARTICLE; ENVELOPE GENE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GROUP SPECIFIC ANTIGEN GENE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MICROBIAL DIVERSITY; POST EXPOSURE PROPHYLAXIS; SCORING SYSTEM; SEROLOGY; STRUCTURAL GENE; VIRUS EXAMINATION; VIRUS GENE;

ADULT; ANTI-HIV AGENTS; ANTIBODY AFFINITY; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; MALAWI; NUCLEIC ACID DENATURATION; POST-EXPOSURE PROPHYLAXIS; UNITED STATES;

EID: 84874532051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057350     Document Type: Article

References (28)

1. Murphy G, Parry JV (2008) Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 13.
2. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, et al. (2009) Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 9: 747-759.
3. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS, (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42: 2623-2628.
4. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, et al. (2008) The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital emergency department. J Acquir Immune Defic Syndr 48: 211-215.
5. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K,et al. (2010) Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. 17th Conf on Retroviruses and Opportunistics Infections 2010; San Francisco, CA: Abstract #937.
6. UNAIDS (2005) UNAIDS reference group on estimates, modelling, and projections' statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Available: http://dataunaidsorg/pub/EPISlides/2006/statement_bed_policy_13dec05_enpdf. Accessed 2012 Mar 22.
7. Karita E, Price M, Hunter E, Chomba E, Allen S, et al. (2007) Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 21: 403-408.
8. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, et al. (2011) Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 28: 816-822.
9. Laeyendecker O, Brookmeyer R, Cousins M, Mullis C, Konikoff J, et al. (2013) HIV incidence determination in clade B epidemics: a multi-assay approach. J Infect Dis 207: 232-239.
10. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, et al. (2013) Use of a multi-faceted approach to assess HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 207: 203-231.
11. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, et al. (2008) Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359: 119-129.
12. Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, et al. (2011) Association of recent HIV infection and in-utero HIV-1 transmission. AIDS 25: 1357-1364.
13. Lihana RW, Ssemwanga D, Abimiku A, Ndembi N, (2012) Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev 14: 83-100.
14. Petch LA, Hoffman IF, Jere CS, Kazembe PN, Martinson FE, et al. (2005) Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses 21: 799-805.
15. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, et al. (2011) Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 6: e27211.
16. Kouyos RD, von Wyl V, Yerly S, Boni J, Rieder P, et al. (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 52: 532-539.
17. Wilson E, Shao W, Brooks J, Dewar R, Kearney M,et al. (2011) New bioinformatic algorithm to identify recent infection. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, Abstract # 1057.
18. Towler WI, James MM, Ray SC, Wang L, Donnell D, et al. (2010) Analysis of HIV diversity using a high resolution melting assay. AIDS Res Hum Retroviruses 26: 913-918.
19. James M, Wang L, Musoke P, Lidstrom J, Towler W, et al. (2011) Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One 6: e18642.
20. James M, Wang L, Barlow-Mosha L, Towler W, Fogel J,et al. (2012) Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J 31: e222- e228.
21. Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, et al. (2012) Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J Clinical Micro 50: 3054-3059.
22. Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, et al. (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. AIDS Res Hum Retroviruses. 23: 764-768.
23. Wheeler WH, Ziebell RA, Zabina H, Pieniazek D, Prejean J, et al. (2010) Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS 24: 1203-1212.
24. Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, et al. (2007) Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS 21: 1165-1174.
25. Long EM, Martin HL Jr, Kreiss JK, Rainwater SM, Lavreys L, et al. (2000) Gender differences in HIV-1 diversity at time of infection. Nat Med 6: 71-75.
26. Ray SC, Quinn TC, (2000) Sex and the genetic diversity of HIV-1. Nature medicine 6: 23-25.
27. Laeyendecker O, Kulich M, Donnell D, Mullis C, Gray RH,et al. (2013) Selection of an optimal multi-assay algorithm for cross-sectional HIV incidence estimation in HPTN 043 (Project Accept). 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA March 3-6 2012.
28. Coates T, Eshleman SH, Chariyalertsak S, Chingono A, Gray G,et al. (2013) Findings on estimates of community-level HIV incidence in HPTN 043 (Project Accept). 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA March 3-6.